Abvc Biopharma Inc Expected To Post A Loss Of 20 Cents A Share: Earnings Preview

ABVC Biopharma

08/08/2022 19:13

* ABVC Biopharma Inc  ABVC.OQ   ABVC.O  is expected to show
a fall
in quarterly revenue when it reports  results on August 10
(estimated). 
    * The Fremont California-based  company is expected to
report  a
90.1% decrease in revenue to $26 thousand from $263.15 thousand
a year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for ABVC Biopharma Inc
is for
a loss of 20 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for ABVC
Biopharma
Inc is $3​, above​ its last closing price of $0.63. ​​​

This summary was machine generated August 8 at 18:13 GMT.  All
figures in US dollars  unless otherwise stated